Half-life (PK) evidence

ATLXM0000225

A single reference-linked measurement — its measured value, assay/model context, and interpretation layer kept separate.

Resources

Manual Explanations Statistics Download

Developability

Profile Comparator

Atlas

About

Half-life (PK)

Measurement

ATLXM0000225

Peptide: ATLPC0030804
Endpoint: Half-life (PK)
ADMET domain: Excretion / Persistence
Value: Observation
5.9 ±2.5 (t1/2 α)
Evidence layer: Reported: reviewed reported observation that should not be pooled as a comparable value yet
Assay / model: Radioimmunoassay · Intravenous injected in New Zeland female rabbits
Condition: Dose/window: 10 μg/kg · Time: 5, 1, 3, 5, 7, 10, 15, 20, 30, 45, 60, 75, and 90 min, then every 30 min until 3 h postinjection, an · New Zeland female rabbits blood protease · in vivo
Reference: Open

This page treats the row as evidence attached to an endpoint and assay context. The layer describes how the row can be interpreted; it is not a safety or developability score by itself.

Download

About

Stack